Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

8.27
Delayed Data
As of Aug 28
 +0.79 / +10.56%
Today’s Change
6.23
Today|||52-Week Range
25.60
-48.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues1.1M4.2M4.2M3.8M
 
 
 
 
 
Depreciation And Amortization398.0K392.0K394.0K404.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.3M13.4M16.7M24.6M
 
 
 
 
 
Research And Development10.2M10.5M13.4M19.2M
 
 
 
 
 
Total Operating Expenses12.7M13.8M17.1M25.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.7M-9.5M-12.9M-21.2M
 
 
 
 
 
Extraordinary Credit1.8M----0.00
 
 
Extraordinary Charge---12.7M-1.8M0.00
 
 
 
Interest Expense On Debt10.0K8.0K8.0K7.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.8M-22.2M-14.5M-21.0M
 
 
 
 
 
Income Taxes0.000.00-4.0K-2.0K
 
 
 
Net Income-9.8M-22.2M-14.5M-21.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.4M46.9M50.1M51.1M
 
 
 
 
 
Shares To Calculate EPS Diluted43.4M46.9M50.1M51.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.47-$0.29-$0.41
 
 
 
 
 
EPS Diluted-$0.23-$0.47-$0.29-$0.41